Deepak Khanna: the legacy of an outgoing ABPI president
March 31, 2014Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Deepak Khanna, NHS, VBP, Whitehead, apbi, jonathan emms
You’d be forgiven for thinking that Deepak Khanna, the man who has overseen the activities of the ABPI for the …
Portland Health hires director from Hanover
March 31, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Hanover, Portland Health, a bpi, comms
Comms agency Portland Health has appointed Matt Worrall as an associate director who joins the firm from Hanover Communications. Worrall …
Life sciences boost from government
March 31, 2014Research and Development, Sales and Marketing DoH, NHS, UK, government, life sciences, medcity
The UK government is to launch an improved offering for the life sciences sector by combining the functions of the …
Stelara hit by final NICE rejection
March 28, 2014Sales and Marketing Janssen, NICE, UK, arthritis, psoriatic, stelar
In final draft guidance released today NICE says it cannot recommend Janssen’s psoriatic arthritis drug Stelara. Specifically, the pricing watchdog …
UK health report flags weight and dementia risks
March 28, 2014Sales and Marketing Dame Sally Davies, Public Health England, dementia, obesity
A new Department of Health report suggests that being overweight is now the norm in England – and that deafness …
Baxter to split in two next year
March 28, 2014Medical Communications, Research and Development, Sales and Marketing AbbVie, Abbott, baxter, biopharma, gambro
Baxter is taking a plunge into the world of restructuring by splitting into two entities: one which is yet to …
MedCity to launch in April
March 28, 2014Medical Communications, Research and Development, Sales and Marketing Boris Johnson, London, UCL, Wellcome, medcity, medical city
The eagerly anticipated launch of ‘MedCity’ will be announced in April, Pharmafile has learned, as the UK government looks to …
CAP-CMV appoints Albrecht Läufer as chief executive
March 28, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Albrecht Läufer, CAP-CMV, cevec
Biotech firm CAP-CMV which is a spin-out of CEVEC Pharmaceuticals has appointed industry veteran Dr Albrecht Läufer as its chief …
AstraZeneca opens up research
March 28, 2014Medical Communications, Sales and Marketing AstraZeneca, data, research, transparency, website
AstraZeneca has created a new means of sharing some of its data with scientists, such as its bank of live …
Europe grants Eperzan licence
March 27, 2014Sales and Marketing Bydureon, GSK, diabetes, eperzan, lilly
The European Commission has granted marketing authorisation to GlaxoSmithKline’s new diabetes treatment Eperzan – setting the manufacturer on a collision …
Alli bottles tampered with in US, drug recalled
March 27, 2014Manufacturing and Production, Sales and Marketing Alli, FDA, GSK, Roche, Xenical, obesity, weight loss
GlaxoSmithKline has admitted that some bottles of its weight-loss drug Alli bought in the US have been tampered with. US …
GSK and partners set up big data project
March 27, 2014Medical Communications, Research and Development, Sales and Marketing Big Data, European Bioinformatics Institute, GSK, Wellcome Trust Sanger Institute, cttv
GlaxoSmithKline, the European Bioinformatics Institute and the Wellcome Trust Sanger Institute have come together to launch an open access research …
NICE launches VBA consultation
March 27, 2014Sales and Marketing Dillon, England, NHS, NICE, VBP, catchpole, pars, vba
NICE has today launched its consultation into how value-based assessment of drugs will work in practice, which will run for …
Immunocore chief executive cements role at Adaptimmune
March 27, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Adaptimmune, immunocore, noble
Biotech firm Adaptimmune has confirmed the full-time appointment of James Noble as its chief executive. Noble has been chief executive …
Adaptimmune wins fund payout
March 26, 2014Research and Development, Sales and Marketing Adaptimmune, Cancer, T cell, biomedical, noble, sme
Biotech firm Adaptimmune has been awarded £2.1 million from the UK government’s Biomedical Catalyst Fund, which was set up to …
UK government launches ‘Sign up to Safety’ initiative
March 26, 2014Sales and Marketing Francis, Hunt, Mid Staffs, NHS, safety, sign up
A new ambition to reduce avoidable harm in the NHS by half over the next three years, cut costs and …
Pfizer’s Xalkori impresses in new setting
March 26, 2014Research and Development, Sales and Marketing NHS, NICE, NSCLC, Pfizer, Xalkori, lung cancer
Pfizer’s lung cancer treatment Xalkori has proven better at treating patients in a first-line setting when compared to chemotherapy. This …
J&J appoints chief design officer
March 26, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ernesto Quinteros, J&J, JJ, belkin, design
Johnson & Johnson has reached outside of its industry and into the design and technology realm with its latest appointment. …
FDA unconvinced on Novartis heart drug
March 26, 2014Research and Development, Sales and Marketing FDA, Novartis, ahf, heart, serelaxin
The prospects of Novartis’ latest heart drug being approved in the US anytime soon appear to have been scuppered by …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
